← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Midi, Inc.
Newark, DE
$1,758,213
Total funding
5
Grants
Funding over time
peak $396.9K · FY2005–18$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$1,609,572 · 4
FDA$148,641 · 1
By mechanism
R44$1,413,416 · 2
R43$344,797 · 3
Investigators at Midi, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
Rapid Susceptibility Testing of MDR M. tuberculosis- Phase II$396,948
R44 · FY2006 · AI
Rapid Susceptibility Testing of MDR M. tuberculosis- Phase II$369,009
R44 · FY2007 · AI
IDENTIFICATION OF BACTERIA DIRECT FROM BLOOD CULTURE$329,994
R44 · FY2002 · AI
IDENTIFICATION OF BACTERIA DIRECT FROM BLOOD CULTURE$317,465
R44 · FY2001 · AI
Authentication quantitation and detection of adulteration in botanical dietary supplements using an automated chemometric platform$148,641
R43 · FY2018 · FD
Prevention of Clostridium difficile-associated disease$99,156
R43 · FY2008 · AI
Rapid Susceptibility Testing of MDR M. tuberculosis$97,000
R43 · FY2005 · AI